Sequence composition, length, and three-dimensional conformation could influence inherent stability
AOD-9604, a synthetic fragment derived from the C-terminal region of human growth hormone, has been subjected to extensive clinical evaluation involving over 900 participants across six randomized controlled trials
the amount of HGF inhibitor that is administered may be in the range of from about 0.1 to about 1,000 mg/kg, an preferably in the range of from about 1 to about 100 mg/kg, although as one of skill in the art will recognize, the precise amount may vary depending on one or more attributes of the drug recipient, including but not limited to: weight, overall health, gender, age, nationality, genetic history, other conditions being treated, etc., and larger or smaller doses are within the practice of this invention
Najrozsdniejszym punktem wyjcia s warunki chodne, suche i osonite od wiata oraz cise przestrzeganie SDS lub noty stabilnoci dla danej partii
Large randomized controlled trials in humans are absent, so clinical efficacy claims lack robust evidence